| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 47.0589 | 37 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.6266 | 40 |
| GSM780709 | Untreated after 4 days (C3_1) | 48.0152 | 41 |
| GSM780719 | Untreated after 4 days (C1_2) | 45.6402 | 30 |
| GSM780720 | Untreated after 4 days (C2_2) | 49.5304 | 47 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.3756 | 29 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.7157 | 35 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 50.9704 | 51 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 56.2336 | 61 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.2073 | 42 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 52.8937 | 56 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 51.7233 | 53 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.8875 | 51 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.8467 | 40 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 55.0386 | 60 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 53.7693 | 58 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 56.0299 | 61 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 55.283 | 60 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 48.8051 | 44 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 51.4198 | 53 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 52.8603 | 56 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 54.6437 | 59 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 57.9235 | 63 |